✦ LIBER ✦

Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma

✍ Scribed by K. Kitamura; T. Takahashi; T. Yamaguchi; T. Yokota; A. Noguchi

Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 89 KB
Volume: 10
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(88)90233-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical application of monoclonal antib

Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma

✍ Toshio Takahashi; Toshiharu Yamaguchi; Kazuya Kitamura; Hiroshi Suzuyama; Mitsuy 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 902 KB

Applications of monoclonal antibodies an

Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas

✍ John W. Greiner; Richard V. Smalley; Ernest C. Borden; Edward W. Martin JR.; Fio 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

Monoclonal antibodies (MAbs) which recognize a human tumor antigen, termed tumor-associated glycoprotein-72 (TAG-72), have successfully been used to localize primary as well as metastatic colorectal tumor lesions in patients. The localization of the anti-TAG-72 MAbs has also been exploited intraoper

High dose rhenium-186-labeling of monocl

High dose rhenium-186-labeling of monoclonal antibodies for clinical application : Pitfalls and solutions

✍ Frank B. van Gog; Gerard W. M. Visser; Joep W. G. Stroomer; Jan C. Roos; Gordon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Background: Rhenium-186 (186re) has ideal properties for adjuvant radioimmunotherapy (rit). however, the lack of suitable methods for high dose 186re labeling of monoclonal antibodies (mabs) has hampered the use of 186re in clinical rit. after development of a chemically identical multistep proc

Application of 99mTc labeled chimeric Fa

Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma

✍ Eigo Otsuji; Hiroomi Matsumura; Kazuma Okamoto; Atsushi Toma; Yoshiaki Kuriu; Da 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Monoclonal antibody conjugated to gadoli

Monoclonal antibody conjugated to gadolinium as a contrast agent for magnetic resonance imaging of human rectal carcinoma

✍ Yoshiaki Kuriu; Eigo Otsuji; Syuichi Kin; Yuen Nakase; Ken-Ichiro Fukuda; Kazuma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Monoclonal antibody U36, a suitable cand

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform

✍ Nicole L.W. Van Hal; Guus A.M.S. Van Dongen; Ellen M.C. Rood-Knippels; Paul Van 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 827 KB

At present, tumor-targeting with monoclonal antibodies ( M U ) is among the most promising novel adjuvant-therapy modalities for the treatment of patients with minimal residual disease of head-and-neck squamous-cell carcinoma (HNSCC For this purpose we developed MAb U36, recognizing a 2 d kDa antige